Compare Adaptive Biotechnologies Corp (ADPT) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Kinder Morgan Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Kinder Morgan Inc trades at $31.59 (market cap $70.10B). The key difference: Kinder Morgan Inc is far larger — about 17.4× Adaptive Biotechnologies Corp's market cap, and Kinder Morgan Inc pays a 3.75% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | KMI | |
|---|---|---|
Market Cap | $4.04B | $70.10B |
Sector | Health | Energy |
52-Week High | $25.45 | $34.31 |
52-Week Low | $12.30 | $25.84 |
Enterprise Value | $4.10B | $102.15B |
Dividend Yield | — | 3.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
